Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice

被引:86
作者
Park, Tae-Sik [1 ]
Panek, Robert L. [1 ]
Rekhter, Mark D. [1 ]
Mueller, Sandra Bak [1 ]
Rosebury, Wendy S. [1 ]
Robertson, Andrew [1 ]
Hanselman, Jeffrey C. [1 ]
Kindt, Erick [1 ]
Homan, Reynold [1 ]
Karathanasis, Sotirios K. [1 ]
机构
[1] Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA
关键词
serine palmitoyltransferase; sphingolipid; cholesterol; lipoprotein; SREBP; atherosclerosis;
D O I
10.1016/j.atherosclerosis.2005.12.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma sphingomyelin (SM) has been suggested as a risk factor for coronary heart disease independent of cholesterol levels. A decrease of SM in lipoproteins is known to improve the activities of lecithin:cholesterol acyltransferase (LCAT) and lipoprotein lipase (LPL) in vitro. Inhibition of SM biosynthesis may reduce lipoprotein SM content and thus improve cholesterol distribution in lipoproteins by enhancing reverse cholesterol transport and clearance of triglyceride-rich lipoproteins. To examine this hypothesis, ApoE KO mice were fed a western diet and treated for 4 weeks with various concentrations of myriocin, a specific inhibitor of serine palmitoyltransferase. Myriocin treatment lowered plasma cholesterol and TG levels in a dose-dependent manner. In addition, myriocin treatment reduced cholesterol contents in VLDL and LDL and elevated HDL-cholesterol. Observed lipid-lowering effects of myriocin were associated with suppression of HMG CoA reductase and fatty acid synthase via reduced levels of SREBP-I RNA and protein. Induction of apoAI and lecithin:cholesterol acytransferase (LCAT) in the liver by myriocin was associated with an increased HDL. Lesion area and macrophage area were also diminished in the cuffed femoral artery of ApoE KO mice. In conclusion, inhibition of sphingolipid biosynthesis can be a novel therapeutic target for dyslipidemia and atherosclerosis. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 35 条
[1]  
Arimoto I, 1998, J LIPID RES, V39, P143
[2]   High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase [J].
Berard, AM ;
Foger, B ;
Remaley, A ;
Shamburek, R ;
Vaisman, BL ;
Talley, G ;
Paigen, B ;
Hoyt, RF ;
Marcovina, S ;
Brewer, HB ;
SantamarinaFojo, S .
NATURE MEDICINE, 1997, 3 (07) :744-749
[3]   Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding [J].
Bolin, DJ ;
Jonas, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19152-19158
[4]  
BOLIN DJ, 1994, J BIOL CHEM, V269, P7429
[5]   The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor [J].
Brown, MS ;
Goldstein, JL .
CELL, 1997, 89 (03) :331-340
[6]   Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys [J].
Egashira, K ;
Zhao, QW ;
Kataoka, C ;
Ohtani, K ;
Usui, M ;
Charo, IF ;
Nishida, K ;
Inoue, S ;
Katoh, M ;
Ichiki, T ;
Takeshita, A .
CIRCULATION RESEARCH, 2002, 90 (11) :1167-1172
[7]   FUNGAL METABOLITES .11. A POTENT IMMUNOSUPPRESSIVE ACTIVITY FOUND IN ISARIA-SINCLAIRII METABOLITE [J].
FUJITA, T ;
INOUE, K ;
YAMAMOTO, S ;
IKUMOTO, T ;
SASAKI, S ;
TOYAMA, R ;
CHIBA, K ;
HOSHINO, Y ;
OKUMOTO, T .
JOURNAL OF ANTIBIOTICS, 1994, 47 (02) :208-215
[8]   Suppression of apolipoprotein Al gene expression in HepG2 cells by TNF α and IL-1β [J].
Haas, MJ ;
Horani, M ;
Mreyoud, A ;
Plummer, B ;
Wong, NCW ;
Mooradian, AD .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1623 (2-3) :120-128
[9]   A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis [J].
Hanada, K ;
Hara, T ;
Nishijima, M ;
Kuge, O ;
Dickson, RC ;
Nagiec, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32108-32114
[10]   Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis [J].
Hoeg, JM ;
SantamarinaFojo, S ;
Berard, AM ;
Cornhill, JF ;
Herderick, EE ;
Feldman, SH ;
Haudenschild, CC ;
Vaisman, BL ;
Hoyt, RF ;
Demosky, SJ ;
Kauffman, RD ;
Hazel, CM ;
Marcovina, SM ;
Brewer, HB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11448-11453